Drooid Logo
Back to story perspectives

Full Breakdown

Carbonated Water Consumption Linked to Reduced Snacking, Alcohol Intake, and Modest Weight Loss in Japanese Adults: Results of a 12-Week Randomized Trial

5/10/2026, 10:56:58 AM

Trial Overview and Primary Findings

A randomized, open-label, placebo-controlled, parallel-group trial published in *Scientific Reports* examined the effects of daily carbonated water consumption on lifestyle behaviors and health indices in Japan. Forty-six healthy Japanese adults (20–64 years, BMI 23.0–<30.0) were allocated to ingest either carbonated water (4.3 ± 0.1 g CO2 per 500 g/day) or non-carbonated water for 12 weeks; 45 participants completed the protocol (carbonated n = 22; placebo n = 23). Primary outcomes included snacking frequency, alcohol intake, body weight, BMI, and liver-related enzymes.

Background and Public-Health Context

Obesity-related, lifestyle-associated diseases remain a leading public-health challenge in Japan, where dietary and drinking patterns significantly influence disease risk. Energy-free carbonated water has been proposed as a low-calorie alternative to sugary drinks and alcoholic beverages, yet empirical evidence on its sustained behavioral and physiological impact has been limited.

Study Timeline and Measurements

  • Baseline (Week 0): Enrollment, randomization, baseline assessments.
  • Week 4: Interim evaluation of snacking frequency.
  • Week 12: Final assessment of snacking frequency, alcohol consumption, anthropometry, and serum liver enzymes (AST, ALT).

Quantitative Outcomes

Compared with the placebo group, the carbonated water group exhibited:

  • A reduction in weekly snacking episodes of 1.39 times at week 4 (95 % CI –2.82 to –0.28; P = 0.018) and 1.49 times at week 12 (95 % CI –2.93 to –0.05; P = 0.049).
  • A decrease in alcohol intake of 24.44 g/week at week 12 (95 % CI –44.02 to –4.86; P = 0.019).
  • Modest weight loss of 0.72 kg (95 % CI –1.37 to –0.07; P = 0.036) and BMI reduction of 0.26 kg/m² (95 % CI –0.50 to –0.02; P = 0.037).
  • Lower serum AST by 4.05 U/L (95 % CI –7.57 to –0.53; P = 0.034) and ALT by 9.47 U/L (95 % CI –18.01 to –0.93; P = 0.026).

No beverage-related adverse events were reported.

Implications for Lifestyle Management

The findings suggest that a simple, calorie-free beverage may influence eating and drinking habits, potentially supporting modest weight management and liver health in populations at risk for obesity-related conditions. If replicated, carbonated water could be incorporated into public-health recommendations as a non-pharmacologic strategy to curb excess caloric intake.

Official Statements & Interpretation

The study authors conclude that daily carbonated water consumption “may be associated with favorable changes in snacking and alcohol consumption behaviors and modest improvements in selected anthropometric and liver-related indices.” They emphasize the exploratory nature of the analyses and advise cautious interpretation.

Limitations and Cautious Interpretation

Critics within the author team note several constraints: the trial’s open-label design, modest sample size, short duration, and lack of multiplicity adjustment for multiple outcomes. These factors limit the strength of causal inference and generalizability beyond the studied cohort.

Conflicting Reports & Gaps

No comparable randomized trials of carbonated water in Japanese or other populations were cited, highlighting a gap in the literature. Replication with larger, blinded samples and longer follow-up is needed to confirm durability of effects.

Verbatim Quotes

  • “Energy-free carbonated water has been suggested to promote sensations of fullness and may serve as a low-caloric alternative to caloric foods or alcoholic beverages; however, evidence regarding its sustained effects on habitual behaviors and objective health indices is limited.” — Study Introduction
  • “These findings suggest that daily consumption of carbonated water may be associated with favorable changes in snacking and alcohol consumption behaviors and modest improvements in selected anthropometric and liver-related indices.” — Conclusion
  • “Given the exploratory nature of the analyses and multiple outcomes without multiplicity adjustment, findings should be interpreted cautiously.” — Conclusion

Future Directions

The authors recommend larger, double-blind trials to verify behavioral and metabolic outcomes, explore dose-response relationships, and assess long-term safety. Integration of objective dietary monitoring could elucidate mechanisms underlying observed reductions in snacking and alcohol use.